News

Net profit of Windlas Biotech declined 0.11% to Rs 17.65 crore in the quarter ended June 2026 as against Rs 17.67 crore during the previous quarter ended June 2025. Sales rose 18.09% to Rs 248.10 crore in the quarter ended June 2026 as against Rs 210.09 crore during the previous quarter ended June 2025. ParticularsQuarter EndedJun. 2026Jun. 2025% Var. Sales248.10210.09 18 OPM %10.7512.63 - PBDT30.1430.71 -2 PBT22.9323.26 -1 NP17.6517.67 0 Powered by Capital Market - Live News

Windlas Biotech will hold a meeting of the Board of Directors of the Company on 10 August 2026.

Windlas Biotech announced that the 25th Annual General Meeting(AGM) of the company will be held on 23 July 2026.

Windlas Biotech announced that the Board of Directors of the Company at its meeting held on 21 May 2026, inter alia, have recommended the final dividend of Rs 6.3 per equity Share (i.e. 126%) , subject to the approval of the shareholders.

Net profit of Windlas Biotech declined 1.78% to Rs 15.99 crore in the quarter ended March 2026 as against Rs 16.28 crore during the previous quarter ended March 2025. Sales rose 17.66% to Rs 238.50 crore in the quarter ended March 2026 as against Rs 202.71 crore during the previous quarter ended March 2025.For the full year,net profit rose 8.97% to Rs 66.46 crore in the year ended March 2026 as against Rs 60.99 crore during the previous year ended March 2025. Sales rose 18.98% to Rs 904.09 crore in the year ended March 2026 as against Rs 759.88 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales238.50202.71 18 904.09759.88 19 OPM %10.6012.60 -11.5912.38 - PBDT28.1629.16 -3 117.72107.74 9 PBT20.1620.82 -3 86.9879.76 9 NP15.9916.28 -2 66.4660.99 9 Powered by Capital Market - Live News